Herein, we aimed at investigating the Si306 capability to increase the radiotherapy efficacy both in normoxic and hypoxic conditions on the GBM cells, increasing the current knowledge on radiosensitizing effects of the novel c-SRC inhibitor Si306. The gene discussed is SRC; the disease is glioblastoma.